Research Article

[Retracted] Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function

Table 2

Comparison of blood pressure, HbA1c, and LDL-C levels ().

IndicesControl group ()Dapagliflozin group ()value value

Systolic blood pressure (mmHg)
 Upon admission128.8614.2422.3870.49
 After 20 weeks of treatment126.0813.1530.3010.78
Diastolic blood pressure (mmHg)
 Upon admission38.0210.96
 After 20 weeks of treatment20.8961.16
HbA1c (%)
 Upon admission51.0560.83
 After 20 weeks of treatment69.0580.94
LDL-C (mm01/L)
 Upon admission40.3400.06
 After 20 weeks of treatment43.3210.01